# Non-alcoholic Fatty Liver Disease and Its Treatment

> **NCT05480007** · NA · COMPLETED · sponsor: **Shanghai 10th People's Hospital** · enrollment: 68 (actual)

## Conditions studied

- NAFLD

## Interventions

- **DRUG:** sitagliptin and metformin
- **DRUG:** Sitagliptin
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT05480007
- **Lead sponsor:** Shanghai 10th People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01-30
- **Primary completion:** 2015-12-01
- **Final completion:** 2018-12-01
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2022-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05480007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05480007, "Non-alcoholic Fatty Liver Disease and Its Treatment". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT05480007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*